ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. Common Stock (ASPI) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for ASP Isotopes Inc. Common Stock (ASPI), covering cash flow, earnings, and balance sheets.
ASP Isotopes Inc. Common Stock (ASPI) Income Statement & Financial Overview
Explore comprehensive income reports for ASP Isotopes Inc. Common Stock ASPI, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.19M | $1.09M | $1.02M | $840354.00 |
| Cost of Revenue | $588141.00 | $793714.00 | $601275.00 | $664694.00 |
| Gross Profit | $605737.00 | $293981.00 | $421024.00 | $175660.00 |
| Gross Profit Ratio | $0.51 | $0.27 | $0.41 | $0.21 |
| R&D Expenses | $1.42M | $1.03M | $473302.00 | $215134.00 |
| SG&A Expenses | $6.84M | $4.69M | $7.41M | $5.78M |
| Operating Expenses | $8.25M | $5.73M | $7.88M | $5.99M |
| Total Costs & Expenses | -$8.84M | $6.52M | $8.48M | $6.66M |
| Interest Income | $580792.00 | $602181.00 | $43530.00 | $12188.00 |
| Interest Expense | $85035.00 | $90966.00 | $69078.00 | $13788.00 |
| Depreciation & Amortization | $45791.00 | $175916.00 | $146504.00 | $103210.00 |
| EBITDA | -$8.94M | -$7.10M | -$8.65M | -$6.90M |
| EBITDA Ratio | -$7.49 | -$6.52 | -$8.46 | -$8.21 |
| Operating Income | -$7.65M | -$5.43M | -$7.46M | -$5.81M |
| Operating Income Ratio | -$6.41 | -$5.00 | -$7.29 | -$6.92 |
| Other Income/Expenses (Net) | -$1.42M | -$1.93M | -$1.41M | -$1.20M |
| Income Before Tax | -$9.07M | -$7.36M | -$8.87M | -$7.01M |
| Income Before Tax Ratio | -$7.59 | -$6.77 | -$8.67 | -$8.34 |
| Income Tax Expense | $153669.00 | -$8370.00 | $13769.00 | -$47619.00 |
| Net Income | -$9.18M | -$7.27M | -$8.93M | -$6.95M |
| Net Income Ratio | -$7.69 | -$6.68 | -$8.74 | -$8.27 |
| EPS | -$0.16 | -$0.12 | -$0.24 | -$0.16 |
| Diluted EPS | -$0.16 | -$0.12 | -$0.24 | -$0.16 |
| Weighted Avg Shares Outstanding | $70.68M | $61.53M | $49.14M | $44.56M |
| Weighted Avg Shares Outstanding (Diluted) | $70.68M | $61.53M | $49.14M | $44.56M |
Over the last four quarters, ASP Isotopes Inc. Common Stock achieved steady financial progress, growing revenue from $840354.00 in Q1 2024 to $1.19M in Q4 2024. Gross profit stayed firm with margins at 51% in Q4 2024 versus 21% in Q1 2024. Operating income totaled -$7.65M in Q4 2024, maintaining a -641% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$8.94M. Net income dropped to -$9.18M, with EPS at -$0.16. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan